Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial

[1] Campos WK(2004)The International Classification of Headache Disorders: 2nd edition Cephalalgia 24 9-160

[2] Linhares MN(2011)A prospective study of 39 patients with trigeminal neuralgia treated with percutaneous balloon compression Arq Neuropsiquiatr 69 221-226

[3] Turp JC(2000)Trigeminal neuralgia--an update Compend Contin Educ Dent 21 279-282

[4] Gobetti JP(2011)Trigeminal neuralgia: the diagnosis and management of this excruciating and poorly understood facial pain Postgrad Med J 87 410-416

[5] Zakrzewska JM(2012)Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2nd Edition J Headache Pain 13 S1-S29

[6] McMillan R(2012)Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial Cephalalgia 32 443-450

[7] Bendtsen L(2011)Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm Turk Neurosurg 21 625-629

[8] Birk S(2010)OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial Cephalalgia 30 793-803

[9] Kasch H(2010)OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial Cephalalgia 30 804-814

[10] Aegidius K(2010)Botulinum toxin in headache treatment: finally a promising path Cephalalgia 30 771-773

[1] Campos WK(2004)The International Classification of Headache Disorders: 2nd edition Cephalalgia 24 9-160

[2] Linhares MN(2011)A prospective study of 39 patients with trigeminal neuralgia treated with percutaneous balloon compression Arq Neuropsiquiatr 69 221-226

[3] Turp JC(2000)Trigeminal neuralgia--an update Compend Contin Educ Dent 21 279-282

[4] Gobetti JP(2011)Trigeminal neuralgia: the diagnosis and management of this excruciating and poorly understood facial pain Postgrad Med J 87 410-416

[5] Zakrzewska JM(2012)Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2nd Edition J Headache Pain 13 S1-S29

[6] McMillan R(2012)Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial Cephalalgia 32 443-450

[7] Bendtsen L(2011)Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm Turk Neurosurg 21 625-629

[8] Birk S(2010)OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial Cephalalgia 30 793-803

[9] Kasch H(2010)OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial Cephalalgia 30 804-814

[10] Aegidius K(2010)Botulinum toxin in headache treatment: finally a promising path Cephalalgia 30 771-773